White Paper
May 2026
Precision is the adherence intervention.
Aspirin works. Yet U.S. preeclampsia rates keep rising. The failure is not pharmacological — it is a failure of risk identification that asks 9 in 10 pregnant women to take a drug they will rationally decline. A look at the evidence for why first-trimester multi-modal screening, not broader checklists, will finally close the preeclampsia prevention gap.
Read white paper